Prospera Financial Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Buy |
+6,098
| New | +$297K | 0.01% | 1108 |
|
|
2024
Q3 | – | Sell |
-3,810
| Closed | -$206K | – | 1132 |
|
|
2024
Q2 | $206K | Sell |
3,810
-408
| -10% | -$22K | 0.01% | 1061 |
|
|
2024
Q1 | $287K | Buy |
+4,218
| New | +$287K | 0.01% | 916 |
|
|
2022
Q3 | – | Sell |
-1,346
| Closed | -$82K | – | 997 |
|
|
2022
Q2 | $82K | Sell |
1,346
-240
| -15% | -$14.6K | ﹤0.01% | 937 |
|
|
2022
Q1 | $100K | Buy |
+1,586
| New | +$100K | ﹤0.01% | 1113 |
|
|
2020
Q4 | – | Sell |
-596
| Closed | -$50K | – | 845 |
|
|
2020
Q3 | $50K | Buy |
+596
| New | +$50K | 0.02% | 617 |
|